中宠股份实控人方拟减持 2017年上市四募资共20亿元

Core Viewpoint - The announcement from Zhongchong Co., Ltd. regarding the share reduction plan by a significant shareholder's action partner indicates that the reduction will not affect the company's control or governance structure, and the company's fundamentals remain stable [1] Group 1: Share Reduction Announcement - Zhongchong Co., Ltd. received a notice from Shanghai Tongyi Investment Management Co., Ltd. regarding the plan to reduce shares by the Tongyi Chunxiao No. 19 private equity fund [1] - The plan involves reducing up to 4.56 million shares, accounting for 1.50% of the total share capital, within three months starting from August 7, 2025 [1] - The reduction will be executed through block trades and/or centralized bidding [1] Group 2: Company Control and Governance - The controlling shareholder of Zhongchong Co., Ltd. is Yantai Zhongxing Biotechnology Co., Ltd., with actual controllers being Hao Zhongli and Xiao Ailing [1] - Tongyi Chunxiao No. 19 is an action partner of the actual controllers, and the share reduction will not lead to a change in control or significant impact on the company's governance structure [1] Group 3: Fundraising History - Zhongchong Co., Ltd. has conducted multiple fundraising activities, including a public offering in 2017 that raised a net amount of 321.97 million yuan [2] - The company also issued convertible bonds in 2019, raising a net amount of approximately 183.50 million yuan after deducting related fees [3] - In 2022, another issuance of convertible bonds raised a net amount of approximately 754.92 million yuan [4] - The total fundraising from these four activities amounts to approximately 2 billion yuan [5]